StockWatch
·

AJANTA PHARMA LTD. Q3 FY25 Results

AJANTPHARMQ3 FY25 Results
Filing
MetricValue (₹ Cr)vs Q2 FY25
Revenue1.1K3.4%
Total Income1.2K2.5%
Expenditure869.185.1%
PBT307.395.9%
Net Profit232.887.6%
OPM20.34%0.93pp
NPM19.79%1.84pp
EPS18.607.7%
View full financials

Informational and educational content only. Not investment advice.